Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02006095 · ClinicalTrials.gov registry record
Neuroimaging Correlates of Memory Decline Following Carotid Interventions
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 207
- Enrollment target
NCT02006095: Completed study, sponsored by Stanford University.
NCT02006095 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 207 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02006095 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 207 participants
- Enrollment target
Study Summary
Carotid revascularization can significantly reduce the risk of stroke in patients with severe carotid stenosis; however, it has been associated with cognitive decline in 25% of the older adults who undergo the procedure. Characterizing risk factors for cognitive decline following carotid interventions and individualizing treatment strategy based on those risks can minimize procedure-associated cognitive dysfunction. Neuroimaging techniques that characterize white matter integrity and regional hypoperfusion have the potential to provide sensitive brain structure indicators that may be associated with memory decline following revascularization procedures. In this protocol, we hope to determine how cerebral blood flow and baseline white matter abnormality in the vulnerable region modify the frequency and cognitive effect of microembolization following carotid revascularization procedures.
Interventions
- BEHAVIORAL Neuropsychological testing
- OTHER Magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2012-11 |
| Est. Completion | 2018-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02006095
The ClinicalTrials.gov registry entry for NCT02006095 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Neuropsychological testing is the first listed.
NCT02006095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02006095 about?
NCT02006095 is a clinical study titled "Neuroimaging Correlates of Memory Decline Following Carotid Interventions". Carotid revascularization can significantly reduce the risk of stroke in patients with severe carotid stenosis; however, it has been associated with cognitive decline in 25% of the older adults who undergo the procedure. Characterizing risk factors for cognitive decline following carotid interventio...
What is the current status of trial NCT02006095?
This trial is currently completed. The enrollment target is 207 participants. The study started on 2012-11. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02006095?
The interventions under investigation include: Neuropsychological testing (BEHAVIORAL), Magnetic resonance imaging (OTHER).
Who is sponsoring clinical trial NCT02006095?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.